Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis

Biochemical and Biophysical Research Communications

Volumn 320, Issue 1, 2004, Pages 165-169

  Gniadecki, Robert ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Apoptosis; CD95; Cholesterol; Fas; Keratinocytes; Lipid rafts

Indexed keywords

CASPASE 8; CHOLESTEROL; CHOLESTEROL OXIDASE; COMPACTIN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FILIPIN; MEMBRANE LIPID; METHYL BETA CYCLODEXTRIN;

APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS, CD95; APOPTOSIS; BETA-CYCLODEXTRINS; CELL LINE; CHOLESTEROL; CHOLESTEROL OXIDASE; CYCLODEXTRINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FILIPIN; HUMANS; KERATINOCYTES; LIGANDS; LOVASTATIN; MEMBRANE FLUIDITY; MEMBRANE MICRODOMAINS;

EID: 2942641691     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.05.145     Document Type: Article

References (35)

1. Brown D.A., London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14:1998;111-136
2. Burger K., Gimpl G., Fahrenholz F. Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. (CMLS). 57:2000;1577-1592
3. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:2000;31-39
4. Edidin M. The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 32:2003;257-283
5. Dykstra M., Cherukuri A., Sohn H.W., Tzeng S.J., Pierce S.K. Location is everything: lipid rafts and immune cell signaling. Annu. Rev. Immunol. 21:2003;457-481
6. Horejsi V. The roles of membrane microdomains (rafts) in T cell activation. Immunol. Rev. 191:2003;148-164
7. Pike L.J., Casey L. Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry. 41:2002;10315-10322
8. Arron J.R., Pewzner-Jung Y., Walsh M.C., Kobayashi T., Choi Y. Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J. Exp. Med. 196:2002;923-934
9. Hueber A.O., Bernard A.M., Hérincs Z., Couzinet A., He H.T. An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes. EMBO Rep. 3:2002;190-196
10. Scheel-Toellner D., Wang K., Singh R., Majeed S., Raza K., Curnow S.J., Salmon M., Lord J.M. The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis. Biochem. Biophys. Res. Commun. 297:2002;876-879
11. Legler D.F., Micheau O., Doucey M.A., Bron C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFα-mediated NF-κB activation. Immunity. 18:2003;655-664
12. Muppidi J.R., Siegel R.M. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat. Immunol. 5:2004;182-189
13. Morita A., Werfel T., Stege H., Ahrens C., Karmann K., Grewe M., Grether-Beck S., Ruzicka T., Kapp A., Klotz L.O., Sies H., Krutmann J. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J. Exp. Med. 186:1997;1763-1768
14. Aragane Y., Kulms D., Metze D., Wilkes G., Poppelmann B., Luger T.A., Schwarz T. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J. Cell Biol. 140:1998;171-182
15. Caricchio R., Reap E.A., Cohen P.L. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis. J. Immunol. 161:1998;241-251
16. Micheau O., Solary E., Hammann A., Dimanche-Boitrel M.T. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem. 274:1999;7987-7992
17. Kulms D., Dussmann H., Poppelmann B., Stander S., Schwarz A., Schwarz T. Apoptosis induced by disruption of the actin cytoskeleton is mediated via activation of CD95 (Fas/APO-1). Cell Death Differ. 9:2002;598-608
18. Bang B., Gniadecki R., Larsen J.K., Baadsgaard O., Skov L. In vivo UVB irradiation induces clustering of Fas (CD95) on human epidermal cells. Exp. Dermatol. 12:2003;791-798
19. Huang H.L., Fang L.W., Lu S.P., Chou C.K., Luh T.Y., Lai M.Z. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene. 22:2003;8168-8177
20. Algeciras-Schimnich A., Shen L., Barnhart B.C., Murmann A.E., Burkhardt J.K., Peter M.E. Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22:2002;207-220
21. Garofalo T., Misasi R., Mattei V., Giammarioli A.M., Malorni W., Pontieri G.M., Pavan A., Sorice M. Association of the death-inducing signaling complex with microdomains after triggering through CD95/Fas. Evidence for caspase-8-ganglioside interaction in T cells. J. Biol. Chem. 278:2003;8309-8315
22. Hill L.L., Ouhtit A., Loughlin S.M., Kripke M.L., Ananthaswamy H.N., Owen-Schaub L.B. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science. 285:1999;898-900
23. Wehrli P., Viard I., Bullani R., Tschopp J., French L.E. Death receptors in cutaneous biology and disease. J. Invest. Dermatol. 115:2000;141-148
24. Viard I., Wehrli P., Bullani R., Schneider P., Holler N., Salomon D., Hunziker T., Saurat J.H., Tschopp J., French L.E. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 282:1998;490-493
25. Scaffidi C., Schmitz I., Zha J., Korsmeyer S.J., Krammer P.H., Peter M.E. Differential modulation of apoptosis sensitivity in CD95 Type I and Type II cells. J. Biol. Chem. 274:1999;22532-22538
26. Braccia A., Villani M., Immerdal L., Niels-Christiansen L.L., Nystrom B.T., Hansen G.H., Danielsen E.M. Microvillar membrane microdomains exist at physiological temperature. Role of galectin-4 as lipid raft stabilizer revealed by "superrafts" J. Biol. Chem. 278:2003;15679-15684
27. Chen X., Resh M.D. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J. Biol. Chem. 277:2002;49631-49637
28. Roepstorff K., Thomsen P., Sandvig K., van Deurs B. Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding. J. Biol. Chem. 277:2002;18954-18960
29. Westover E.J., Covey D.F., Brockman H.L., Brown R.E., Pike L.J. Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects: studies with cholesterol enantiomers. J. Biol. Chem. 278:2003;51125-51133
30. Gniadecki R., Bang B. Flotillas of lipid rafts in transit amplifying cell-like keratinocytes. J. Invest. Dermatol. 121:2003;522-528
31. Jakobisiak M., Golab J. Potential antitumor effects of statins. Int. J. Oncol. 23:2003;1055-1069
32. Wong W.W., Dimitroulakos J., Minden M.D., Penn L.Z. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia. 16:2002;508-519
33. Dimitroulakos J., Nohynek D., Backway K.L., Hedley D.W., Yeger H., Freedman M.H., Minden M.D., Penn L.Z. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: a potential therapeutic approach. Blood. 93:1999;1308-1318
34. Rao S., Porter D.C., Chen X., Herliczek T., Lowe M., Keyomarsi K. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc. Natl. Acad. Sci. USA. 96:1999;7797-7802
35. Li H.Y., Appelbaum F.R., Willman C.L., Zager R.A., Banker D.E. Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Blood. 101:2003;3628-3634